Remdesivir Completed Phase 3 Trials for COVID / Coronavirus Disease 2019 (COVID‑19) / Severe Acute Respiratory Syndrome (SARS) Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Completed | Treatment | 3 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT04546581 | Inpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC) |